Effect of Clarithromycin in Patients with Sepsis and Ventilator‐Associated Pneumonia

Abstract

Clarithromycin accelerated the resolution of VAP and weaning from mechanical ventilation in surviving patients and delayed death in those who died of sepsis. The mortality rate at day 28 was not altered. Results are encouraging and render new perspectives on the management of sepsis and VAP.